Search research articles
Contact Us
Filters
Showing results (1-10 of 137) with videos related to
Page
of 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2017
Is It Time for New Target Volumes in Radiation Oncology?
David Palma
Oral Oncology
|
March 2, 2010
Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: is doxycycline the missing link?
David Palma
The Annals of Thoracic Surgery
|
December 22, 2010
Stereotactic lung radiotherapy: do we need fiducial markers?
Suresh Senan, David Palma
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2021
Too Big to Fail: Miracle Drugs or False Hope?
Pencilla Lang, David Palma
Cancer
|
March 11, 2008
Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy
David Palma, Tom Pickles
The Lancet. Oncology
|
November 18, 2008
Prostate cancer and host metabolic factors
David Palma, Tom Pickles
Current Opinion in Oncology
|
November 26, 2010
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer
David Palma, Suresh Senan
The Lancet. Oncology
|
February 17, 2019
CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer
Faiez AlShafa, David Palma
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2017
Oligometastatic non-small cell lung cancer: Where do we go next?
Nauman Malik, David Palma
International Journal of Radiation Oncology, Biology, Physics
|
July 23, 2019
In Reply to Banfill et al
David Palma, Tina Zhang
Page
of 14
Search research articles
Search
Showing results (1-10 of 137) with videos related to
Sort By:
Page
of 14
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2017
Is It Time for New Target Volumes in Radiation Oncology?
David Palma
Oral Oncology
|
March 2, 2010
Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: is doxycycline the missing link?
David Palma
The Annals of Thoracic Surgery
|
December 22, 2010
Stereotactic lung radiotherapy: do we need fiducial markers?
Suresh Senan, David Palma
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2021
Too Big to Fail: Miracle Drugs or False Hope?
Pencilla Lang, David Palma
Cancer
|
March 11, 2008
Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy
David Palma, Tom Pickles
The Lancet. Oncology
|
November 18, 2008
Prostate cancer and host metabolic factors
David Palma, Tom Pickles
Current Opinion in Oncology
|
November 26, 2010
Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer
David Palma, Suresh Senan
The Lancet. Oncology
|
February 17, 2019
CHISELing a path forward in the treatment of early-stage non-small-cell lung cancer
Faiez AlShafa, David Palma
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2017
Oligometastatic non-small cell lung cancer: Where do we go next?
Nauman Malik, David Palma
International Journal of Radiation Oncology, Biology, Physics
|
July 23, 2019
In Reply to Banfill et al
David Palma, Tina Zhang
Page
of 14